US Bancorp’s Aptose Biosciences, Inc. APTO Stock Holding History

US Bancorp’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-67	Closed	-$455	–	4423
2024 Q4	$455	Hold	67	–	–	﹤0.01%	4031
2024 Q3	$830	Hold	67	–	–	﹤0.01%	3912
2024 Q2	$1.53K	Hold	67	–	–	﹤0.01%	3758
2024 Q1	$3.35K	Hold	67	–	–	﹤0.01%	3619
2023 Q4	$5.13K	Hold	67	–	–	﹤0.01%	3522
2023 Q3	$5.66K	Hold	67	–	–	﹤0.01%	3392
2023 Q2	$9.37K	Hold	67	–	–	﹤0.01%	3282
2023 Q1	$19.4K	Hold	67	–	–	﹤0.01%	3015
2022 Q4	$17.6K	Hold	67	–	–	﹤0.01%	3058
2022 Q3	$18K	Hold	67	–	–	﹤0.01%	3087
2022 Q2	$22K	Hold	67	–	–	﹤0.01%	3009
2022 Q1	$41K	Hold	67	–	–	﹤0.01%	2727
2021 Q4	$41K	Hold	67	–	–	﹤0.01%	2758
2021 Q3	$66K	Hold	67	–	–	﹤0.01%	2511
2021 Q2	$101K	Hold	67	–	–	﹤0.01%	2305
2021 Q1	$181K	Hold	67	–	–	﹤0.01%	1971
2020 Q4	$133K	Hold	67	–	–	﹤0.01%	2070
2020 Q3	$182K	Hold	67	–	–	﹤0.01%	1818
2020 Q2	$191K	Hold	67	–	–	﹤0.01%	1778
2020 Q1	$180K	Hold	67	–	–	﹤0.01%	1719
2019 Q4	$172K	Hold	67	–	–	﹤0.01%	1910
2019 Q3	$63K	Hold	67	–	–	﹤0.01%	2361
2019 Q2	$79K	Hold	67	–	–	﹤0.01%	2328
2019 Q1	$61K	Hold	67	–	–	﹤0.01%	2402
2018 Q4	$58K	Hold	67	–	–	﹤0.01%	2378
2018 Q3	$79K	Hold	67	–	–	﹤0.01%	2341
2018 Q2	$119K	Hold	67	–	–	﹤0.01%	2135
2018 Q1	$96K	Hold	67	–	–	﹤0.01%	2266
2017 Q4	$68K	Hold	67	–	–	﹤0.01%	2450
2017 Q3	$45K	Buy	+67	New	+$45K	﹤0.01%	2619

Other funds holding APTO

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

US Bancorp's APTO Position: Q1 2025 in Review

US Bancorp sold out of Aptose Biosciences, Inc. (APTO) in Q1 2025, closing a stake of 67 shares — an estimated $455 sold.

US Bancorp first reported a position in APTO in Q3 2017 and held it in 30 quarters. The position peaked at $191K in Q2 2020. 16 funds tracked by Wall St. Rank hold APTO as of Q1 2025.

US Bancorp reported no remaining Aptose Biosciences, Inc. position as of Q1 2025 after selling out during the quarter.
US Bancorp sold 67 Aptose Biosciences, Inc. shares in Q1 2025, an estimated $455.
US Bancorp first reported a position in Aptose Biosciences, Inc. in Q3 2017 and held it in 30 quarters.
US Bancorp's Aptose Biosciences, Inc. position peaked at $191K in Q2 2020.
16 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.